NYSE$CHE
Chemed Corp · Q4 2024 earnings
Q4 2024 earnings · · After market close · Investor relations
Briefing
Chemed reported solid Q4 2024 financial results, driven by strong performance in the VITAS segment.
Chemed Corporation reported Q4 2024 revenue of $640.0 million, an increase of 9.2% year-over-year. Net income attributable to common stock was $90.3 million, with EPS of $6.02 and adjusted EPS of $6.83. VITAS segment revenue grew 17.4%, while Roto-Rooter saw a slight revenue decline. Free cash flow remained strong, and the company repurchased shares worth $212.8 million.
- Revenue increased 9.2% to $640.0 million.
- Net income attributable to common stock was $90.3 million.
- EPS reached $6.02, with adjusted EPS at $6.83.
- VITAS revenue grew 17.4%, while Roto-Rooter declined 2.9%.
Headline financials
Revenue & EPS history
Chemed · Revenue · Quarterly
$640M
Revenue by segment
Chemed · $565M total across 2 segments · Q3 2023
- VITAS Healthcare$334M+12.4%59.1%
- Roto-Rooter$231M+0.3%40.9%
Forward guidance
Chemed anticipates continued growth in 2025, with VITAS revenue expected to rise by 10.5% to 11.3% and Roto-Rooter revenue projected to grow by 2.4% to 3.0%. Adjusted EPS is estimated to be between $24.95 and $25.45.
Tailwinds
- VITAS revenue expected to grow between 10.5% and 11.3%.
- Roto-Rooter revenue projected to increase between 2.4% and 3.0%.
- Expected full-year adjusted EBITDA margin of 18.4% to 18.9% for VITAS.
- Medicare Cap billing limitations estimated at $9.5 million.
- Strong share repurchase program with $255.3 million remaining authorization.
Headwinds
- Medicare Cap rate increase lower than reimbursement rate increase, reducing cushion.
- Roto-Rooter revenue growth expected to be slower in early 2025.
- Higher costs expected due to ongoing expansion in VITAS.
- Potential impact from labor market constraints in healthcare and plumbing sectors.
- Economic uncertainty may impact demand for non-essential services.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2024
+0.7%
Avg return
Earnings day
+0.9%
Avg return
5 days after
+2.1%
Avg return
30 days after
53%
36 / 68 earnings
Positive
+13.0%
Q3 2015
Best reaction
-14.8%
Q4 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -0.4% | -0.1% | +4.0% | |
| Q4 2025 | -14.8% | -9.1% | -21.0% | |
| Q3 2025 | +6.0% | +0.4% | +0.1% | |
| Q1 2025 | -6.6% | -1.8% | -2.7% | |
| Q4 2024 | +7.4% | +7.7% | +11.0% | |
| Q3 2024 | -12.0% | -12.7% | -6.2% | |
| Q2 2024 | -0.1% | +2.4% | +5.7% | |
| Q1 2024 | -7.0% | -8.1% | -9.9% | |
| Q4 2023 | +5.1% | +2.6% | +7.3% | |
| Q3 2023 | +9.3% | +10.9% | +14.4% | |
| Q2 2023 | -8.1% | -8.0% | -10.8% | |
| Q1 2023 | -3.7% | -2.2% | -4.1% | |
| Q4 2022 | +3.3% | +1.7% | +1.9% | |
| Q3 2022 | +3.2% | +4.1% | +12.6% | |
| Q2 2022 | -6.8% | -9.2% | -8.3% | |
| Q1 2022 | -1.4% | -1.0% | +0.8% | |
| Q4 2021 | +5.1% | +5.8% | +3.8% | |
| Q3 2021 | +9.2% | +9.0% | +9.4% | |
| Q2 2021 | -4.4% | -0.4% | -2.4% | |
| Q1 2021 | +1.5% | +2.3% | +6.1% | |
| Q4 2020 | -0.8% | -6.7% | -3.9% | |
| Q3 2020 | +1.2% | +3.5% | +0.2% | |
| Q2 2020 | +9.0% | +10.3% | +12.2% | |
| Q1 2020 | -3.9% | -6.5% | +5.6% | |
| Q4 2019 | +3.2% | -1.2% | -23.1% | |
| Q3 2019 | -1.7% | +0.6% | +5.9% | |
| Q2 2019 | +3.7% | +8.1% | +13.9% | |
| Q1 2019 | -0.6% | +0.7% | +0.3% | |
| Q4 2018 | +1.3% | +2.8% | +1.9% | |
| Q3 2018 | +6.2% | +6.6% | +7.6% | |
| Q2 2018 | +0.4% | -2.5% | +0.1% | |
| Q1 2018 | +3.0% | +3.3% | +13.4% | |
| Q4 2017 | +2.4% | +2.1% | +12.9% | |
| Q3 2017 | +9.1% | +5.0% | +12.7% | |
| Q2 2017 | -1.1% | -2.3% | -6.3% | |
| Q1 2017 | +10.0% | +9.4% | +9.0% | |
| Q4 2016 | +1.9% | +2.0% | +9.1% | |
| Q3 2016 | -0.3% | +1.8% | +6.3% | |
| Q2 2016 | +5.0% | +3.0% | -7.9% | |
| Q1 2016 | -6.7% | — | — | |
| Q4 2015 | -5.6% | — | — | |
| Q3 2015 | +13.0% | — | — | |
| Q2 2015 | +5.1% | — | — | |
| Q1 2015 | -4.7% | — | — | |
| Q4 2014 | +7.5% | — | — | |
| Q3 2014 | -1.2% | — | — | |
| Q2 2014 | +4.3% | — | — | |
| Q1 2014 | -3.3% | — | — | |
| Q4 2013 | +10.5% | — | — | |
| Q3 2013 | -5.2% | — | — | |
| Q2 2013 | -7.3% | — | — | |
| Q1 2013 | +3.4% | — | — | |
| Q4 2012 | +4.9% | — | — | |
| Q3 2012 | -2.0% | — | — | |
| Q2 2012 | +5.1% | — | — | |
| Q1 2012 | +2.9% | — | — | |
| Q4 2011 | +0.0% | — | — | |
| Q3 2011 | +1.5% | — | — | |
| Q2 2011 | -5.8% | — | — | |
| Q1 2010 | -2.6% | — | — | |
| Q1 2011 | +1.8% | — | — | |
| Q4 2008 | -1.6% | — | — | |
| Q4 2010 | -1.6% | — | — | |
| Q3 2009 | +1.4% | — | — | |
| Q3 2010 | +1.4% | — | — | |
| Q2 2010 | -0.9% | — | — | |
| Q2 2009 | -0.9% | — | — | |
| Q4 2009 | -0.9% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro